DK0944611T3 - Dimesylatsalte af neuropeptid Y-ligander - Google Patents

Dimesylatsalte af neuropeptid Y-ligander

Info

Publication number
DK0944611T3
DK0944611T3 DK97910602T DK97910602T DK0944611T3 DK 0944611 T3 DK0944611 T3 DK 0944611T3 DK 97910602 T DK97910602 T DK 97910602T DK 97910602 T DK97910602 T DK 97910602T DK 0944611 T3 DK0944611 T3 DK 0944611T3
Authority
DK
Denmark
Prior art keywords
neuropeptide
ligands
dimesylate
salts
dimesylate salts
Prior art date
Application number
DK97910602T
Other languages
Danish (da)
English (en)
Inventor
Douglas J M Allen
Lyle R Brostrom
Alireza S Kord
Laurie A Whipple
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0944611T3 publication Critical patent/DK0944611T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK97910602T 1996-11-26 1997-11-19 Dimesylatsalte af neuropeptid Y-ligander DK0944611T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3181596P 1996-11-26 1996-11-26
PCT/IB1997/001465 WO1998023603A1 (en) 1996-11-26 1997-11-19 Dimesylate salts of neuropeptide y ligands

Publications (1)

Publication Number Publication Date
DK0944611T3 true DK0944611T3 (da) 2004-04-13

Family

ID=21861551

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97910602T DK0944611T3 (da) 1996-11-26 1997-11-19 Dimesylatsalte af neuropeptid Y-ligander

Country Status (23)

Country Link
US (1) US5914329A (https=)
EP (1) EP0944611B1 (https=)
JP (1) JP3120861B2 (https=)
AP (1) AP9701148A0 (https=)
AR (1) AR010304A1 (https=)
AT (1) ATE257472T1 (https=)
AU (1) AU4792497A (https=)
BR (1) BR9713538A (https=)
CA (1) CA2272927C (https=)
DE (1) DE69727155T2 (https=)
DK (1) DK0944611T3 (https=)
ES (1) ES2213207T3 (https=)
GT (1) GT199700123A (https=)
HN (1) HN1997000154A (https=)
HR (1) HRP970640A2 (https=)
ID (1) ID18964A (https=)
MA (1) MA26450A1 (https=)
PA (1) PA8441701A1 (https=)
PE (1) PE17099A1 (https=)
PT (1) PT944611E (https=)
TN (1) TNSN97191A1 (https=)
WO (1) WO1998023603A1 (https=)
ZA (1) ZA9710587B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001053477A1 (en) * 2000-01-20 2001-07-26 Baylor College Of Medicine Methods and compositions for control of bone formation via modulation of neuropeptide y activity
WO2003049673A2 (en) 2001-12-05 2003-06-19 Baylor College Of Medicine Methods and compositions for control of bone formation via modulation of sympathetic tone
ATE321865T1 (de) 2002-01-09 2006-04-15 Arexis Ab Mutationsnachweis
ES2333739T3 (es) * 2004-11-23 2010-02-26 Dong Wha Pharmaceutical Co., Ltd. Sal de n-hidroxi-4-(5-(4-(5-isopropil-2-metil-1,3-tiazol-4-il)fenoxi) pentoxi)benzamidina con acido 2-metanosulfonico.
WO2006108218A1 (en) * 2005-04-15 2006-10-19 Regenertech Pty Limited Use of neuropeptide y (npy) and agonists and antagonists thereof for tissue regeneration

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996014307A1 (en) * 1994-11-07 1996-05-17 Pfizer Inc. Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands

Also Published As

Publication number Publication date
JP3120861B2 (ja) 2000-12-25
EP0944611A1 (en) 1999-09-29
JP2000505110A (ja) 2000-04-25
MA26450A1 (fr) 2004-12-20
GT199700123A (es) 1999-05-19
ID18964A (id) 1998-05-28
PT944611E (pt) 2004-04-30
PA8441701A1 (es) 2000-05-24
DE69727155T2 (de) 2004-07-08
US5914329A (en) 1999-06-22
WO1998023603A1 (en) 1998-06-04
PE17099A1 (es) 1999-02-19
EP0944611B1 (en) 2004-01-07
DE69727155D1 (de) 2004-02-12
CA2272927C (en) 2003-02-04
AU4792497A (en) 1998-06-22
BR9713538A (https=) 2000-03-21
TNSN97191A1 (fr) 2005-03-15
ZA9710587B (en) 1999-05-25
CA2272927A1 (en) 1998-06-04
ES2213207T3 (es) 2004-08-16
AP9701148A0 (en) 1998-01-31
HRP970640A2 (en) 1998-10-31
ATE257472T1 (de) 2004-01-15
AR010304A1 (es) 2000-06-07
HN1997000154A (es) 1999-02-09

Similar Documents

Publication Publication Date Title
DK1064298T3 (da) Inhibitorer af caspaser
IS4880A (is) Innlyksa kompexar af arýl - heterósýklískum söltum
DK0966430T3 (da) Anti-flammatoriske forbindelser
DK1004669T3 (da) Hidtil ukendte differentieringsinhibitor
IS2027B (is) Ný spíróasabísýklísk heterósýklísk efnasambönd
ATE261935T1 (de) Neue metformin salze und verfahren
FI962749L (fi) Uusia heterosyklisiä yhdisteitä
DE60142480D1 (de) Einstellung von aufnahmebedingungen in einer kamera
DE69932378D1 (de) Automatisches Ausrichten von Druckköpfen
FI971635L (fi) Menetelmät neuropeptidiin Y liittyvien tilojen inhiboimiseksi
DK0796207T3 (da) Bærer af klemmetypen
DE69736445D1 (de) Refluxinhibitoren
DK0745011T3 (da) Dannelse af gevind
DE69811326D1 (de) Chromenverbindungen
DK0695383T3 (da) Efterbehandling af non-woven-duge
DK0944611T3 (da) Dimesylatsalte af neuropeptid Y-ligander
DK1035128T3 (da) Fremgangsmåde til fremstilling af raffinosekrystaller
DK0950051T3 (da) Mikropartikulær form af en tetrahydropyridinforbindelse
DK0883623T3 (da) Fremstilling af chirale titanocener
ATA88199A (de) Schalbauteil
SE9704542D0 (sv) Novel pyridazinone compounds
SE9402122D0 (sv) Heterocyclic compounds
SE9400968D0 (sv) Heterocyclic compounds
DK0815473T3 (da) Bestemmelse af en parameter for en komponent i en sammensætning
FI961298A0 (fi) Laserkaepp foer synskadade